MAP3K13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.794600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.027800E-01
Normal-vs-Stage2
2.170600E-01
Normal-vs-Stage3
6.919800E-01
Normal-vs-Stage4
2.635800E-01
Stage1-vs-Stage2
5.792000E-01
Stage1-vs-Stage3
3.869000E-01
Stage1-vs-Stage4
3.785800E-01
Stage2-vs-Stage3
2.921600E-01
Stage2-vs-Stage4
4.714200E-01
Stage3-vs-Stage4
2.440600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.046600E-01
Normal-vs-AfricanAmerican
1.977560E-01
Normal-vs-Asian
2.029000E-01
Caucasian-vs-AfricanAmerican
6.473000E-01
Caucasian-vs-Asian
4.838400E-01
AfricanAmerican-vs-Asian
9.529400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.493200E-01
Normal-vs-Female
3.343400E-01
Male-vs-Female
4.778000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.720800E-01
Normal-vs-Age(41-60Yrs)
1.438600E-01
Normal-vs-Age(61-80Yrs)
3.649000E-01
Normal-vs-Age(81-100Yrs)
6.244600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.784800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.078000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.622200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.684700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.663600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.183600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.943800E-01
Normal-vs-Daily Drinker
4.884200E-01
Normal-vs-Weekly Drinker
5.542200E-01
Normal-vs-Occasional Drinker
1.916030E-01
Normal-vs-Social Drinker
1.365220E-01
Non Drinker-vs-Daily Drinker
4.282200E-01
Non Drinker-vs-Weekly Drinker
4.643800E-01
Non Drinker-vs-Occasional Drinker
4.020800E-01
Non Drinker-vs-Social Drinker
9.789800E-01
Daily Drinker-vs-Weekly Drinker
9.501200E-01
Daily Drinker-vs-Occasional Drinker
1.463240E-01
Daily Drinker-vs-Social Drinker
4.564000E-01
Weekly Drinker-vs-Occasional Drinker
1.980980E-01
Weekly Drinker-vs-Social Drinker
4.677400E-01
Occasional Drinker-vs-Social Drinker
3.862400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.038580E-01
Normal-vs-Grade 2
4.412000E-02
Normal-vs-Grade 3
1.585850E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.803910E-02
Grade 1-vs-Grade 3
9.580500E-04
Grade 1-vs-Grade 4
1.038580E-01
Grade 2-vs-Grade 3
1.835210E-01
Grade 2-vs-Grade 4
4.412000E-02
Grade 3-vs-Grade 4
1.585850E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.581000E-01
Normal-vs-NonDiabetic
2.872800E-01
Diabetic-vs-NonDiabetic
9.239800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.310810E-01
Normal-vs-NoPancreatitis
3.246800E-01
Pancreatitis-vs-NoPancreatitis
2.172800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.423200E-01
Normal-vs-N1
2.250600E-01
N0-vs-N1
6.007800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.854400E-02
Normal-vs-TP53-NonMutant
2.573200E-01
TP53-Mutant-vs-TP53-NonMutant
2.572500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
